AstraZeneca Plc to supply Europe with coronavirus vaccine

AstraZeneca Plc to supply Europe with coronavirus vaccine

Starting by the end of 2020, British drugmaker AstraZeneca Plc will supply European countries with a vaccine against the coronavirus.

“With our European supply chain due to begin production soon, we hope to make the vaccine available widely and rapidly,” Chief Executive Pascal Soriot said in a statement.

The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said, Reuters reports.

The experimentation phase of the vaccine is already advanced and expected to end in the autumn, Italian Health Minister Roberto Speranza said in a Facebook post